Nanoparticle-based drug delivery involves the use of nanoparticles as carriers to transport therapeutic agents directly to cancer cells. These nanoparticles can be engineered to improve the solubility, stability, and bioavailability of drugs, ensuring that they reach the targeted site in the body more effectively than conventional methods.
